Marla Persky - Nov 14, 2023 Form 4 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role
Director
Signature
/s/ Beth Hecht, as Attorney-in-Fact
Stock symbol
XERS
Transactions as of
Nov 14, 2023
Transactions value $
$10,058
Form type
4
Date filed
11/15/2023, 04:13 PM
Previous filing
Jun 7, 2023
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XERS Common Stock Purchase $10.1K +6.37K $1.58 6.37K Nov 14, 2023 By: Marla Susan Persky Revocable Trust u/a dated 9/23/2000 F1
holding XERS Common Stock 57.5K Nov 14, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.